Suppr超能文献

采用热法和非热法对盐酸异丙嗪与片剂辅料进行相容性研究。

Compatibility studies of promethazine hydrochloride with tablet excipients by means of thermal and non-thermal methods.

作者信息

Thumma S, Repka M A

机构信息

Department of Pharmaceutics, School of Pharmacy, The University of Mississippi, University, MS 38677, USA.

出版信息

Pharmazie. 2009 Mar;64(3):183-9.

Abstract

The compatibility of promethazine hydrochloride (PMZ) with various tableting excipients has been investigated by isothermal stress testing (IST) and differential scanning calorimetry (DSC). DSC thermograms of PMZ and each of the excipients investigated were compared with their corresponding physical mixtures (1:1) for evaluation. Furthermore, Fourier transform infrared spectroscopy (FTIR) data was used to corroborate the results of DSC and IST. A preliminary sustained release tablet formulation of the drug, prepared using compatible excipients, was stored under accelerated storage conditions (40 degrees C/75% RH) and analyzed for stability, drug release and bioadhesion characteristics for up to 3 months. Based on DSC results alone, drug-excipient interactions were observed with Pearlitol SD200, lactose monohydrate and zinc stearate. Chromatographic analysis of the stressed binary mixture (stored at 55 degrees C for 3 weeks) containing PMZ-lactose monohydrate showed brown discoloration indicating potential interaction. However, stressed physical mixtures of PMZ-Pearlitol SD200 and PMZ-zinc stearate indicated compatibility as opposed to the thermal analysis. The tablet formulation was found to be very stable after 3 months of storage at accelerated stability conditions. Also, the release profiles and bioadhesive properties were found to be unaltered. Thus, both thermal and non-thermal methods were utilized to successfully evaluate the compatibility of excipients with PMZ and the tablet formulation was found to be stable.

摘要

通过等温应力测试(IST)和差示扫描量热法(DSC)研究了盐酸异丙嗪(PMZ)与各种片剂辅料的相容性。将PMZ和每种所研究辅料的DSC热谱图与其相应的物理混合物(1:1)进行比较以进行评估。此外,利用傅里叶变换红外光谱(FTIR)数据来证实DSC和IST的结果。使用相容性辅料制备的该药物的初步缓释片剂制剂在加速储存条件(40℃/75%相对湿度)下储存,并分析其长达3个月的稳定性、药物释放和生物粘附特性。仅基于DSC结果,观察到PMZ与Pearlitol SD200、一水乳糖和硬脂酸锌之间存在药物-辅料相互作用。对含有PMZ-一水乳糖的受压二元混合物(在55℃下储存3周)进行色谱分析,结果显示有褐色变色,表明可能存在相互作用。然而,PMZ-Pearlitol SD200和PMZ-硬脂酸锌的受压物理混合物显示出相容性,这与热分析结果相反。在加速稳定性条件下储存3个月后,发现该片剂制剂非常稳定。此外,还发现其释放曲线和生物粘附特性未发生改变。因此,热分析和非热分析方法均被用于成功评估辅料与PMZ的相容性,并且发现该片剂制剂是稳定的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验